Ciardiello, Davide
Blauensteiner, Bernadette
Matrone, Nunzia
Belli, Valentina
Mohr, Thomas
Vitiello, Pietro Paolo
Martini, Giulia
Poliero, Luca
Cardone, Claudia
Napolitano, Stefania
De Falco, Vincenzo
Giunta, Emilio Francesco
Ciaramella, Vincenza
Corte, Carminia della
Barra, Giusi
Selvaggi, Francesco
Franco, Renato
Marino, Federica Zito
Cuomo, Antonio
Morgillo, Floriana
Troiani, Teresa
Sibilia, Maria
Ciardiello, Fortunato
Martinelli, Erika http://orcid.org/0000-0002-7108-0971
Funding for this research was provided by:
Associazione Iblea per la Ricerca Epidemiologica (Grant number MFAG-2015-ID: 7778)
I-Cure Research Project (Grant number: Cup 21C17000030007)
European Research Council (ERC) Advanced grant (ERC-2015-AdG TNT-Tumors 694883)
H2020 Marie Skłodowska-Curie Actions (766214)
Università degli Studi della Campania Luigi Vanvitelli
Article History
Received: 28 August 2020
Accepted: 12 January 2021
First Online: 11 February 2021
Compliance with ethical standards
:
: DC reports travel grant from Sanofi; FM: Advisory Boards: MSD, Lilly; Institutional Research Grants: AstraZeneca; TT reports advisory board for Amgen, Bayer, Merck, Novartis, Roche, Sanofi; FC reports advisory board for Merck, Roche, Amgen, Bayer, Servier, Symphogen, Pfizer and research funding from Roche, Merck, Amgen, Bayer, Ipsen; EM advisory board for Amgen, Bayer, Merck, Roche, Sanofi, Servier and expert opinion for ESMO (European Society of Medical Oncology); all the other authors reports no conflict of interest.
: The present study was approved by the Ethic Committee of the University of Campania “Luigi Vanvitelli.”
: All the patients signed an informed consent for the use of clinical information and tumor samples.